{"id":227758,"date":"2025-05-07T00:37:43","date_gmt":"2025-05-07T00:37:43","guid":{"rendered":"https:\/\/peraltafinancing.com\/business\/finance\/mid-cap-medical-stocks-crushing-the-market\/"},"modified":"2025-05-07T00:37:43","modified_gmt":"2025-05-07T00:37:43","slug":"mid-cap-medical-stocks-crushing-the-market","status":"publish","type":"post","link":"https:\/\/fivemor.com\/?p=227758","title":{"rendered":"Mid-Cap Medical Stocks Crushing the Market"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div id=\"articlecontent\">\n<p>While major market indexes like the <strong>S&amp;P 500<\/strong> have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several\u00a0<span style=\"box-sizing: border-box; margin: 0px; padding: 0px;\"><a href=\"https:\/\/www.marketbeat.com\/stocks\/sectors\/medical\/\" target=\"_blank\" rel=\"noopener\">medical and biotechnology sector<\/a> <strong>mid-cap stocks<\/strong>\u00a0<\/span>have stood out for their resilience and outperformance. Investors looking beyond large-cap names may find compelling opportunities in mid-cap stocks that deliver strong growth and defy broader market weakness.<\/p>\n<p>Here are <strong>three mid-cap medical stocks<\/strong> that have significantly outperformed the broader market so far this year. Each shows strong momentum, bullish analyst sentiment, and potential for continued upside.<\/p>\n<div class=\"mb-4 mx-0 row border-top border-bottom pr-2 py-2 align-items-center\" style=\"font-size:1rem; border-color:var(--gray-4);clear:both;\">\n<p><label for=\"InPostRegistrationEmail\" class=\"w-100 p-1 d-flex flex-wrap justify-content-start align-items-center mb-0 c-blue font-small\"><span class=\"fa-regular fa-bullhorn mr-2\"\/><span style=\"line-height:1em;\">Get <strong>TransMedics Group<\/strong> alerts:<\/span><\/label><\/p>\n<p><input id=\"InPostRegistrationEmail\" name=\"RegisterEmail\" type=\"text\" placeholder=\"Enter Your Email Address\" class=\"col-12 col-sm-8 m-0 mb-1 mb-sm-0 top-labeled-input font-small\"\/><button id=\"signUpButton\" type=\"button\" class=\"btn btn-featured col-12 col-sm-4\" style=\"margin:0!important;border:none!important\">Sign Up<\/button><\/p>\n<\/div>\n<h2>Penumbra: A High-Growth Medical Devices Company Outperforming the Market<\/h2>\n<div class=\"content-module \" data-content-module=\"CompanyOverview\" data-company=\"NYSE:PEN\">\n<div class=\"alignleft bg-white border rounded\" style=\"width:350px;max-width:100%\">\n<div class=\"p-2 p-md-3\">\n<h3 class=\"section-h h6 mt-0 mb-3 pt-0\">Penumbra Today<\/h3>\n<div class=\"d-flex mb-1\">\n<div class=\"py-2 pr-2 mr-2 text-center company-thumbnail border-right mb-1\" style=\"width:55px\"><img decoding=\"async\" loading=\"lazy\" height=\"11\" width=\"55\" src=\"https:\/\/www.marketbeat.com\/logos\/thumbnail\/penumbra-inc-logo.jpg\" alt=\"Penumbra, Inc. stock logo\"\/><\/div>\n<\/div>\n<div class=\"d-inline-block mb-2 mr-4\"><strong style=\"font-size:1.7em;color: var(--blue-11);\">$292.21<\/strong> <strong style=\"color:#D2333D\"> -0.92\u00a0(-0.31%)<\/strong> <\/p>\n<div class=\"price-updated\">As of 03:59 PM Eastern <\/p>\n<div class=\"inline-always-moreinfo moreinfo bg-white\" tabindex=\"0\"><span class=\"fa-regular fa-circle-info c-gray\" aria-hidden=\"true\"\/><span style=\"font-size:.8em;width:170px;\" class=\"tooltiptext\" id=\"tooltip-fmv\">This is a fair market value price provided by Polygon.io. <a href=\"http:\/\/www.marketbeat.com\/about\/#data\">Learn more.<\/a><\/span><\/div>\n<\/div>\n<\/div>\n<dl>\n<div class=\"price-data w-range\">\n<dt class=\"range-label\">52-Week Range<\/dt>\n<dd class=\"range-meter\">$148.00<\/p>\n<p><span class=\"range-marker\" style=\"left:89%\"><span class=\"range-arrow\">\u25bc<\/span><\/span><\/p>\n<p>$310.00<\/dd>\n<\/div>\n<p><dt>P\/E Ratio<\/dt>\n<dd><strong>859.43<\/strong><\/dd>\n<\/p>\n<p><dt>Price Target<\/dt>\n<dd><strong>$302.40<\/strong><\/dd>\n<\/p>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/PEN\/\">Penumbra, Inc. <span class=\"hoverDetails\" data-prefix=\"NYSE\" data-symbol=\"PEN\">NYSE: PEN<span class=\"saved-tooltiptext d-none\"\/><\/span><\/a> designs, develops, manufactures, and markets innovative medical devices used in neuro and vascular interventions. With a market capitalization of $11.3 billion, the company has emerged as a standout performer in the medical device space. While recession concerns and geopolitical uncertainty have weighed on equities broadly, Penumbra\u2019s stock is up an impressive <strong>23% year-to-date<\/strong> and 43% over the past 12 months.<\/p>\n<p>The company reported <a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-4-23-penumbra-inc-stock\/\">strong first-quarter earnings on April 23<\/a>, posting <strong>earnings per share of $0.83<\/strong>, beating consensus estimates by $0.17. Revenue climbed 16.3% year-over-year to $324.1 million, exceeding expectations of $315.7 million. Despite market volatility in April, Penumbra held its uptrend and <strong>trades just 5% below its 52-week high<\/strong>, indicating continued investor confidence.<\/p>\n<p>Valuation remains elevated, with a trailing <strong>P\/E ratio of 274<\/strong>, though its <strong>forward P\/E of 58<\/strong> better reflects its growth trajectory. <a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/PEN\/forecast\/\">Analysts remain bullish<\/a>. Of the 17 analysts covering the stock, the consensus rating is a <strong>Moderate Buy<\/strong>, with a price target that points to further potential upside.<\/p>\n<h2>TransMedics Group: Momentum and Growth in Organ Transplant Technology<\/h2>\n<div class=\"content-module \" data-content-module=\"CompanyOverview\" data-company=\"NASDAQ:TMDX\">\n<div class=\"alignleft bg-white border rounded\" style=\"width:350px;max-width:100%\">\n<div class=\"p-2 p-md-3\">\n<h3 class=\"section-h h6 mt-0 mb-3 pt-0\">TransMedics Group Today<\/h3>\n<div class=\"d-flex mb-1\">\n<div class=\"py-2 pr-2 mr-2 text-center company-thumbnail border-right mb-1\" style=\"width:55px\"><img decoding=\"async\" loading=\"lazy\" height=\"26\" width=\"29\" src=\"https:\/\/www.marketbeat.com\/logos\/thumbnail\/transmedics-group-inc-logo.png?v=20240424104726\" alt=\"TransMedics Group, Inc. stock logo\"\/><\/div>\n<div><a class=\"mr-2 font-12 nounderline\" href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/TMDX\/\">TMDX<\/a><a rel=\"nofollow\" href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/TMDX\/chart\/\"><img decoding=\"async\" src=\"https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/vertical-align:top;width:50px;\" class=\"sparkline\" alt=\"TMDX 90-day performance\" title=\"90-day performance\" bad-src=\"https:\/\/www.marketbeat.com\/Scripts\/sparklines.ashx?prefix=NASDAQ&amp;symbol=TMDX\"\/><\/a><\/p>\n<p>TransMedics Group<\/p>\n<\/div>\n<\/div>\n<div class=\"d-inline-block mb-2 mr-4\"><strong style=\"font-size:1.7em;color: var(--blue-11);\">$93.38<\/strong> <strong style=\"color:#11824D\"> +1.17\u00a0(+1.27%)<\/strong> <\/p>\n<p>As of 04:00 PM Eastern<\/p>\n<\/div>\n<dl>\n<div class=\"price-data w-range\">\n<dt class=\"range-label\">52-Week Range<\/dt>\n<dd class=\"range-meter\">$55.00<\/p>\n<p><span class=\"range-marker\" style=\"left:31%\"><span class=\"range-arrow\">\u25bc<\/span><\/span><\/p>\n<p>$177.37<\/dd>\n<\/div>\n<p><dt>P\/E Ratio<\/dt>\n<dd><strong>99.34<\/strong><\/dd>\n<\/p>\n<p><dt>Price Target<\/dt>\n<dd><strong>$124.20<\/strong><\/dd>\n<\/p>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/TMDX\/\">TransMedics Group <span class=\"hoverDetails\" data-prefix=\"NASDAQ\" data-symbol=\"TMDX\">NASDAQ: TMDX<span class=\"saved-tooltiptext d-none\"\/><\/span><\/a> is a <strong>commercial-stage medical technology company<\/strong> revolutionizing organ transplant procedures. The firm\u2019s flagship product, the Organ Care System (OCS), preserves donor organs in near-physiological conditions, significantly extending the window for transplantation. The company also offers the National OCS Program, a turnkey solution for organ retrieval and logistics.<\/p>\n<p>The stock began to rally in April after breaking out above key resistance around $80. Since then, shares have gained substantial momentum and are now<strong> up nearly 48% year-to-date.<\/strong> The stock\u2019s high P\/E ratio of 91 may give some investors pause, but its <strong>forward P\/E of 41<\/strong> suggests strong earnings growth ahead.<\/p>\n<p>Analysts are optimistic about the company\u2019s outlook. Eleven analysts cover the stock, all contributing to a <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/TMDX\/forecast\/\">Moderate Buy consensus rating<\/a>. The consensus price target implies up to <strong>35% upside<\/strong> from current levels.<\/p>\n<p>One catalyst and factor contributing to the stock&#8217;s surge and momentum is its high short interest. As of April 15, <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/TMDX\/short-interest\/\">short interest stood at 28%<\/a> of the float, about 8.8 million shares. While down 7.3% from the prior month, the elevated level may contribute to a <strong>short squeeze<\/strong> dynamic, fueling the rally.<\/p>\n<h2>ADMA Biologics: Biotech Strength With Room to Run<\/h2>\n<div class=\"content-module \" data-content-module=\"CompanyOverview\" data-company=\"NASDAQ:ADMA\">\n<div class=\"alignleft bg-white border rounded\" style=\"width:350px;max-width:100%\">\n<div class=\"p-2 p-md-3\">\n<h3 class=\"section-h h6 mt-0 mb-3 pt-0\">ADMA Biologics Today<\/h3>\n<div class=\"d-flex mb-1\">\n<div class=\"py-2 pr-2 mr-2 text-center company-thumbnail border-right mb-1\" style=\"width:55px\"><img decoding=\"async\" loading=\"lazy\" height=\"15\" width=\"55\" src=\"https:\/\/www.marketbeat.com\/logos\/thumbnail\/adma-biologics-inc-logo.png?v=20221208104654\" alt=\"ADMA Biologics, Inc. stock logo\"\/><\/div>\n<\/div>\n<div class=\"d-inline-block mb-2 mr-4\"><strong style=\"font-size:1.7em;color: var(--blue-11);\">$23.15<\/strong> <strong style=\"color:#D2333D\"> -0.56\u00a0(-2.37%)<\/strong> <\/p>\n<div class=\"price-updated\">As of 03:59 PM Eastern <\/p>\n<div class=\"inline-always-moreinfo moreinfo bg-white\" tabindex=\"0\"><span class=\"fa-regular fa-circle-info c-gray\" aria-hidden=\"true\"\/><span style=\"font-size:.8em;width:170px;\" class=\"tooltiptext\" id=\"tooltip-fmv\">This is a fair market value price provided by Polygon.io. <a href=\"http:\/\/www.marketbeat.com\/about\/#data\">Learn more.<\/a><\/span><\/div>\n<\/div>\n<\/div>\n<dl>\n<div class=\"price-data w-range\">\n<dt class=\"range-label\">52-Week Range<\/dt>\n<dd class=\"range-meter\">$6.72<\/p>\n<p><span class=\"range-marker\" style=\"left:87%\"><span class=\"range-arrow\">\u25bc<\/span><\/span><\/p>\n<p>$25.67<\/dd>\n<\/div>\n<p><dt>P\/E Ratio<\/dt>\n<dd><strong>82.67<\/strong><\/dd>\n<\/p>\n<p><dt>Price Target<\/dt>\n<dd><strong>$22.50<\/strong><\/dd>\n<\/p>\n<\/dl>\n<\/div>\n<\/div>\n<\/div>\n<p><a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/ADMA\/\">ADMA Biologics <span class=\"hoverDetails\" data-prefix=\"NASDAQ\" data-symbol=\"ADMA\">NASDAQ: ADMA<span class=\"saved-tooltiptext d-none\"\/><\/span><\/a> is a biopharmaceutical company that develops, manufactures, and markets plasma-derived biologics for treating immune deficiencies and infectious diseases. With a <strong>market cap of $5.6 billion<\/strong>, it\u2019s one of the most <strong>impressive biotech performers of 2025<\/strong>, with shares <strong>up 38% year-to-date<\/strong>.<\/p>\n<p>The stock is trading just 7% below its all-time high, which was reached in late April. Investors will be watching closely as the company is scheduled to <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/ADMA\/earnings\/\">report earnings on May 7<\/a>. ADMA trades at a P\/E of 29 and a forward P\/E of 23, supported by projected EPS growth of 45% in 2025.<\/p>\n<p>Despite limited analyst coverage, only four analysts cover the stock, all of them <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/ADMA\/forecast\/\">rate it as a Buy<\/a>, reinforcing the stock\u2019s strong growth profile and favorable risk-reward balance.<\/p>\n<p>Before you consider TransMedics Group, you&#8217;ll want to hear this.<\/p>\n<p>MarketBeat keeps track of Wall Street&#8217;s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the <a href=\"https:\/\/www.marketbeat.com\/newsletter\/PDFoffer.aspx?offer=top5&amp;RegistrationCode=ArticlePage-ShouldYouInvest\">five stocks<\/a> that top analysts are quietly whispering to their clients to buy now before the broader market catches on&#8230; and TransMedics Group wasn&#8217;t on the list.<\/p>\n<p>While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.<\/p>\n<p><a class=\"btn btn-featured\" style=\"text-decoration:none\" href=\"https:\/\/www.marketbeat.com\/newsletter\/PDFoffer.aspx?offer=top5&amp;RegistrationCode=ArticlePage-ShouldYouInvest\">View The Five Stocks Here <span class=\"mr-3 fa-regular fa-angle-right\" aria-hidden=\"true\"\/><\/a><\/p>\n<div class=\"mt-4 pt-2 mb-3\">\n<div class=\"bg-light-blue rounded\">\n<div class=\"row align-content-center justify-content-center \">\n<div class=\"col-12 col-sm-4 col-md-3 position-relative pr-sm-0 pb-1 d-flex justify-content-center align-items-start\"><img loading=\"lazy\" decoding=\"async\" height=\"209\" width=\"170\" class=\"mt-2 position-relative\" src=\"https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/max-width:100%;height:auto;z-index:1;margin-top:-0.75em!important;\" alt=\"2025 Gold Forecast: A Perfect Storm for Demand Cover\"\/><\/div>\n<div class=\"col-12 col-sm-8 col-md-9 px-0 pr-sm-3 pl-sm-0\">\n<div class=\"p-4 p-sm-3 h-100 text-center text-sm-left\">\n<p class=\"font-small mb-2\" style=\"line-height:1.3em;\">Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you&#8217;re planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.<\/p>\n<p><a class=\"upper-link\" style=\"text-decoration:none; color:var(--blue); font-size:1rem;\" href=\"https:\/\/marketbeat.com\/newsletter\/pdfoffer.aspx?offer=gold&amp;RegistrationCode=ArticlePage-FreeReport\">Get This Free Report<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n<div>\n<p>Like this article? Share it with a colleague.<\/p>\n<p>                    <a title=\"Share on Facebook\" href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/\" target=\"_blank\" rel=\"nofollow noopener\" class=\"btn btn-share\"><span class=\"fa-brands fa-facebook-f\"\/><\/a><a title=\"Share on Twitter\" href=\"https:\/\/twitter.com\/intent\/tweet?text=3+Mid-Cap+Medical+Stocks+Outperforming+the+Market%20%24TMDX%20%23TMDX%20https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/\" target=\"_blank\" rel=\"nofollow noopener\" class=\"btn btn-share\"><span class=\"fa-brands fa-x-twitter\"\/><\/a><a title=\"Share on LinkedIn\" onclick=\"window.open('https:\/\/www.linkedin.com\/cws\/share?mini=true&amp;url=https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/', 'name','width=600,height=600')\" href=\"https:\/\/www.linkedin.com\/cws\/share?mini=true&amp;url=https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/\" target=\"popup\" rel=\"nofollow noopener\" class=\"btn btn-share\"><span class=\"fa-brands fa-linkedin-in\"\/><\/a><a title=\"Share on StockTwits\" href=\"https:\/\/api.stocktwits.com\/widgets\/share?via=MarketBeat&amp;body=3+Mid-Cap+Medical+Stocks+Outperforming+the+Market%20https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/\" target=\"_blank\" rel=\"nofollow noopener\" class=\"btn btn-share\"><span class=\"fa-kit fa-stocktwits-mark\"\/><\/a><a title=\"Print this page\" href=\"https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/javascript:window.print()\" class=\"btn btn-share\"><span class=\"fa-regular fa-print\"\/><\/a><a title=\"Email this page\" href=\"mailto:?subject=3%20Mid-Cap%20Medical%20Stocks%20Outperforming%20the%20Market&amp;body=Check%20out%20this%20stock%3A%20https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/%0D%0A%0D%0AFor%20real-time%20financial%20news%20and%20analysis%2C%20visit%20https%3A%2F%2Fwww.marketbeat.com%2F%20.\" class=\"btn btn-share\"><span class=\"fa-regular fa-envelope\"\/><\/a><a title=\"Copy the URL of this page to the clipboard\" href=\"https:\/\/www.marketbeat.com\/stock-ideas\/3-mid-cap-medical-stocks-outperforming-the-market\/\" class=\"btn btn-share shareCopy\"><span class=\"fa-regular fa-link\"\/><\/a><\/p>\n<p>Link copied to clipboard.<\/p>\n<\/p><\/div>\n<p><script async src=\"\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><br \/>\n<br \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>While major market indexes like the S&amp;P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several\u00a0medical and biotechnology sector mid-cap stocks\u00a0have stood out for their resilience and outperformance. Investors looking beyond large-cap names may find compelling opportunities in mid-cap stocks [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":227759,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[93],"tags":[16768,11209,4560,43855,11046],"dealstore":[],"offerexpiration":[],"class_list":["post-227758","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance","tag-crushing","tag-market","tag-medical","tag-midcap","tag-stocks"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mid-Cap Medical Stocks Crushing the Market - Som2ny Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fivemor.com\/?p=227758\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mid-Cap Medical Stocks Crushing the Market - Som2ny Network\" \/>\n<meta property=\"og:description\" content=\"While major market indexes like the S&amp;P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several\u00a0medical and biotechnology sector mid-cap stocks\u00a0have stood out for their resilience and outperformance. Investors looking beyond large-cap names may find compelling opportunities in mid-cap stocks [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fivemor.com\/?p=227758\" \/>\n<meta property=\"og:site_name\" content=\"Som2ny Network\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-07T00:37:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fivemor.com\/?p=227758#article\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\"},\"headline\":\"Mid-Cap Medical Stocks Crushing the Market\",\"datePublished\":\"2025-05-07T00:37:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758\"},\"wordCount\":831,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg\",\"keywords\":[\"Crushing\",\"Market\",\"Medical\",\"MidCap\",\"Stocks\"],\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fivemor.com\/?p=227758#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fivemor.com\/?p=227758\",\"url\":\"https:\/\/fivemor.com\/?p=227758\",\"name\":\"Mid-Cap Medical Stocks Crushing the Market - Som2ny Network\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg\",\"datePublished\":\"2025-05-07T00:37:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fivemor.com\/?p=227758#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fivemor.com\/?p=227758\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/?p=227758#primaryimage\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg\",\"width\":1200,\"height\":750},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fivemor.com\/?p=227758#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fivemor.com\/?bp_activities=1\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mid-Cap Medical Stocks Crushing the Market\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fivemor.com\/#website\",\"url\":\"https:\/\/fivemor.com\/\",\"name\":\"Som2ny Network\",\"description\":\"Daily Deals\",\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fivemor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fivemor.com\/#organization\",\"name\":\"Som2ny Network\",\"url\":\"https:\/\/fivemor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"width\":300,\"height\":86,\"caption\":\"Som2ny Network\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/fivemor.com\"],\"url\":\"https:\/\/fivemor.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mid-Cap Medical Stocks Crushing the Market - Som2ny Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fivemor.com\/?p=227758","og_locale":"en_US","og_type":"article","og_title":"Mid-Cap Medical Stocks Crushing the Market - Som2ny Network","og_description":"While major market indexes like the S&amp;P 500 have struggled to gain traction in 2025 and remain in the red YTD, certain pockets of the market are showing impressive strength. Several\u00a0medical and biotechnology sector mid-cap stocks\u00a0have stood out for their resilience and outperformance. Investors looking beyond large-cap names may find compelling opportunities in mid-cap stocks [&hellip;]","og_url":"https:\/\/fivemor.com\/?p=227758","og_site_name":"Som2ny Network","article_published_time":"2025-05-07T00:37:43+00:00","og_image":[{"width":1200,"height":750,"url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fivemor.com\/?p=227758#article","isPartOf":{"@id":"https:\/\/fivemor.com\/?p=227758"},"author":{"name":"admin","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371"},"headline":"Mid-Cap Medical Stocks Crushing the Market","datePublished":"2025-05-07T00:37:43+00:00","mainEntityOfPage":{"@id":"https:\/\/fivemor.com\/?p=227758"},"wordCount":831,"commentCount":0,"publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"image":{"@id":"https:\/\/fivemor.com\/?p=227758#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg","keywords":["Crushing","Market","Medical","MidCap","Stocks"],"articleSection":["Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fivemor.com\/?p=227758#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fivemor.com\/?p=227758","url":"https:\/\/fivemor.com\/?p=227758","name":"Mid-Cap Medical Stocks Crushing the Market - Som2ny Network","isPartOf":{"@id":"https:\/\/fivemor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fivemor.com\/?p=227758#primaryimage"},"image":{"@id":"https:\/\/fivemor.com\/?p=227758#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg","datePublished":"2025-05-07T00:37:43+00:00","breadcrumb":{"@id":"https:\/\/fivemor.com\/?p=227758#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fivemor.com\/?p=227758"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/?p=227758#primaryimage","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/05\/med_20250506112938_3-mid-cap-medical-stocks-outperforming-the-market.jpg","width":1200,"height":750},{"@type":"BreadcrumbList","@id":"https:\/\/fivemor.com\/?p=227758#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fivemor.com\/?bp_activities=1"},{"@type":"ListItem","position":2,"name":"Mid-Cap Medical Stocks Crushing the Market"}]},{"@type":"WebSite","@id":"https:\/\/fivemor.com\/#website","url":"https:\/\/fivemor.com\/","name":"Som2ny Network","description":"Daily Deals","publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fivemor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fivemor.com\/#organization","name":"Som2ny Network","url":"https:\/\/fivemor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","width":300,"height":86,"caption":"Som2ny Network"},"image":{"@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","caption":"admin"},"sameAs":["https:\/\/fivemor.com"],"url":"https:\/\/fivemor.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/227758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=227758"}],"version-history":[{"count":0,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/227758\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/media\/227759"}],"wp:attachment":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=227758"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=227758"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=227758"},{"taxonomy":"dealstore","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fdealstore&post=227758"},{"taxonomy":"offerexpiration","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fofferexpiration&post=227758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}